Research Center for Biosciences and Health Technologies. Universidade Lusófona. Lisboa. Portugal.
Departamento de Sócio-Farmácia. Faculdade de Farmácia. Universidade de Lisboa. Lisboa. Portugal.
Acta Med Port. 2021 Mar 1;34(3):201-208. doi: 10.20344/amp.13419.
Medical devices are healthcare technologies with a significantly growing market worldwide. This study aims to analyze medical device alerts issued by the Portuguese Medicines Agency, INFARMED, I.P. during 2017, as well as to identify the respective regulatory actions and to suggest additional recommendations.
All alerts on medical device alerts publicly available in the website of INFARMED, I.P. were identified and analyzed, including actions taken. Additionally, reports on medical devices from the Portuguese national competent authorities were compared with reports from other European Union member states such as Germany.
A total of 32 safety alerts were identified: 18 (56%) related with devices without identified records of commercialization in Portugal, six (19%) related with devices voluntarily withdrawn from the market, such as counterfeit products, and eight (25%) categorized as 'other'. In both Portugal and Germany, 0.28 and 4.53 reports of national competent authorities per million inhabitants were identified, respectively. Diverse regulatory actions were taken, such as six compulsory indications to not acquire or use devices.
Considering that the European Union is an open market where citizens should have equal access to medical devices, the Portuguese system of medical device safety alerts seems to be functioning normally. The identified safety alerts seemed relevant, with Portugal registering a proportionally slightly lower number of alerts when compared with higher sales volume markets, which may be explained by an underreporting of this type of problems. Further studies are needed to confirm these preliminary results, although the development of databases comprising data on patients using medical devices is recommended in order to generate automatic email and text message alerts.
A limited number of safety alerts on medical devices was identified in Portugal, with few reported cases of counterfeit or falsified devices. The Portuguese Medicines Agency contributes to the citizens' access to quality medical devices, by issuing safety alerts, recommendations and mandatory market withdrawals for unsuitable or unsafe medical devices.
医疗器械是全球市场上呈显著增长趋势的医疗技术。本研究旨在分析 2017 年葡萄牙药品管理局 INFARMED,I.P. 发布的医疗器械警报,并确定相应的监管措施,并提出其他建议。
在 INFARMED,I.P. 的网站上识别并分析了所有公开的医疗器械警报,包括采取的行动。此外,还将葡萄牙国家主管当局的医疗器械报告与德国等其他欧盟成员国的报告进行了比较。
共发现 32 项安全警报:18 项(56%)与未在葡萄牙记录有商业化的设备有关,6 项(19%)与自愿从市场撤回的设备有关,如假冒产品,8 项(25%)归类为“其他”。在葡萄牙和德国,分别确定了每百万居民 0.28 和 4.53 份国家主管当局的报告。采取了各种监管行动,例如六项强制性指示,要求不购买或使用设备。
考虑到欧盟是一个开放市场,公民应该平等地获得医疗器械,葡萄牙的医疗器械安全警报系统似乎运行正常。所发现的安全警报似乎是相关的,与销售额较高的市场相比,葡萄牙的警报数量比例略低,这可能是由于这类问题的报告不足所致。需要进一步研究来证实这些初步结果,尽管建议开发包含使用医疗器械的患者数据的数据库,以便生成自动电子邮件和短信警报。
在葡萄牙发现的医疗器械安全警报数量有限,报告的假冒或伪造设备案例很少。葡萄牙药品管理局通过发布安全警报、建议和对不适合或不安全的医疗器械进行强制性市场撤回,为公民获得高质量医疗器械做出了贡献。